Gastrointestinal tolerability of onceweekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss
1 2 Alhonen, L., Parkkinen, J
10.1186/s13054-018-2197-4 [DOI] [PMC free article] [PubMed] [Google Scholar] 62.Samson SL, Vellanki P, Blonde L, Christofides EA, Galindo RJ, Hirsch IB et al (2023) American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm - 2023 Update
The nexus of regenerative medicine and infectious disease treatment is a fascinating frontier
This awe-inspiring Inca citadel, carved into the mountains and surrounded by towering Andean peaks, will take your breath away